Less Ads, More Data, More Tools Register for FREE

Pin to quick picksT42 Iot Track. Regulatory News (TRAC)

Share Price Information for T42 Iot Track. (TRAC)

Share Price is delayed by 15 minutes
Get Live Data
4.20    0.05 (1.20%)
Bid:
4.10
Ask:
4.30
Spread: 0.20 (4.878%)
Market Cap: £3.07m
TRAC Live PriceLast checked at - London Stock Exchange

Intraday T42 Iot Track. Share Chart

Director Change

1 Dec 2021 17:39

RNS Number : 2872U
T42 IOT Tracking Solutions PLC
01 December 2021
 

1 December 2021

 

t42 IoT Tracking Solutions PLC

("t42" or the "Company")

 

Director Change

 

 

The Board of t42 announces today that Mr Avi Engel, who has served as a non- executive director of the Company since 2015, is to leave the Board with effect from 31 December 2021 to pursue other activities. Mr Engel has been a valuable member of the Board for several years and we thank him for his contribution and wish him every success in his future endeavours.

 

Under the terms of his contract, Mr Engel was granted 2,009,302 share options in return for a reduction in his monthly fees until 31 May 2022. After the recent share consolidation this amount equated to 251,162 options and with his departure from the Board, it has been agreed that this amount will reduce on a pro-rata basis to 209,302 options. These options are due to vest on 31 March 2022 and are exercisable until 31 March 2032.

 

The Company will be seeking to appoint an additional non-executive director to the Board in due course.

 

 

Contacts:

 

t42 IoT Tracking Solutions PLC

Michael Rosenberg, Chairman

Avi Hartmann, CEO

 

 

07785 727595

+972 5477 35663

Allenby Capital Limited (AIM Nominated Adviser and Joint Broker)

Jeremy Porter/Piers Shimwell

 

020 3328 5656

Peterhouse Capital Limited (Joint Broker)

Lucy Williams/Charles Goodfellow/Eran Zucker

 

020 7469 0930

Yellow Jersey PR (Financial PR)

Tom Randell/Henry Wilkinson/Annabelle Wills

020 3004 9512

t42@yellowjerseypr.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADFLFBFLLXFBE
Date   Source Headline
22nd May 20264:30 pmRNSNotice of AGM
13th Apr 202610:03 amRNS2025 Final Results
13th Apr 20267:00 amRNS-RNew Australasia Distribution Partnership
30th Mar 20267:00 amRNS-RDistribution Partnership
9th Mar 20267:00 amRNSTrading Update
5th Jan 202611:45 amRNSAGM Results, Director Dealings, Change of Auditor
18th Dec 20259:05 amRNSNotice of AGM
1st Dec 20259:10 amRNSReplacement - Appointment of broker
1st Dec 20257:00 amRNSAppointment of broker
16th Oct 20257:00 amRNSUpdate re shipping container tracking
29th Aug 20257:02 amRNSInterim Results
12th Aug 20257:00 amRNSContguard Convertible Loan Extension & Order
29th Jul 20257:00 amRNSExtension of CLN
16th May 20257:00 amRNSExtension of CLN Redemption Dates
7th Apr 20257:00 amRNSBusiness Update & Board Change
6th Feb 20252:34 pmRNSPlacing to raise £262,500
16th Dec 20242:05 pmRNSResult of AGM
16th Dec 202411:00 amRNSProject Agreement Secured Evaluated at over US$5m
28th Nov 20247:00 amRNSNotice of AGM
30th Sep 20249:10 amRNSInterim Results
29th Aug 20243:25 pmRNSChange of Auditor
29th Aug 20247:00 amRNSHolding(s) in Company
22nd Aug 20248:25 amRNSDirector's Share Transfer
26th Jun 20247:00 amRNS2023 Final Results
21st May 20241:34 pmRNSt42 enters into a significant agreement
13th May 202412:00 pmRNSLong Term Agreement
16th Apr 202411:14 amRNSt42 enters significant agreement in Mexico
7th Mar 20249:39 amRNST42 year-end trading update and CLN extension
5th Feb 20247:00 amRNSSignificant Long-Term Agreement
22nd Jan 20249:42 amRNSUpdate re CLN and Exercise of Options
17th Jan 20241:35 pmRNSUpdate re CLN and Exercise of Options
17th Jan 20247:00 amRNSUpdate re CLN and Exercise of Options
20th Dec 20237:00 amRNSUpdate re Convertible Loan Notes
1st Dec 20237:00 amRNSSatellite-Based 5G IoT Maritime Tracking Solution
14th Nov 20232:02 pmRNSResult of AGM
26th Oct 20237:00 amRNSNotice of AGM
16th Oct 202311:15 amRNSEquity Fundraise Exercise of Options
9th Oct 20231:42 pmRNSStatement re actions on Israel
27th Sep 20231:43 pmRNSInterim Results
25th Sep 20237:00 amRNSNotice of Results
13th Sep 20238:07 amRNSNotice of Interim Results and Business Update
1st Aug 202310:00 amRNSChange of Registered Address
26th Jul 202312:30 pmRNS$1.3 million raise through Convertible Loan
17th Jul 20237:00 amRNSt42 Solution Collaboration
4th Jul 20237:00 amRNSFurther Order of Tetis Units
28th Jun 20233:45 pmRNS2022 Final Results
4th May 20233:45 pmRNSStrategic partnership with Israel’s largest port
13th Mar 202312:30 pmRNSFurther order of 2,500 Tetis units in the USA
1st Mar 20234:40 pmRNSSecond Price Monitoring Extn
1st Mar 20234:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.